- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06178042
Effectiveness of MI Paste Plus and Remin Pro on Remineralization of Post-Orthodontic White Spot Lesions
Evaluation of the Efficiency of Different Remineralization Methods Used In the Treatment of Post-Orthodontic White Spot Lesions With Quantitative Light-Induced Fluorescence Method
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled trial was a parallel arm 1-1 allocations. The study carried out in the Orthodontics Department, Izmir Katip Celebi University, Turkey. The protocol of the trial was approved by the Izmir Katip Celebi University Research Ethics Committee. A power analysis was carried out to provide that there was enough power to apply a statistical test of the research hypothesis to compare caries regression of Remin Pro to MI Paste Plus comparing with a control group in the remineralization of postorthodontic WSLs. Patients who finished their fixed appliance treatment in the clinic of the Department of Orthodontics, Faculty of Dentistry, Izmir Katip Celebi University who were found to comply with the study criteria were informed. Patients and parents who agreed to participate in the study signed an informed consent. A total of 39 people, 22 women and 17 men, aged between 14 and 23, were included in the study, with 13 people in each group. Gender distribution and average age of the groups are similar. Patients who are 12 to 25 years of age, at least had 12 months of orthodontic treatment with braces, at least had one upper anterior tooth with WSL included in the study. Patient who are smoking, with enamel hypoplasia or fluorosis, with active periodontal disease, with dentin caries, with allergy to casein, with previous bleaching excluded. Simple randomization was performed at the start of the study using a random number table prepared using SPSS software (version 26.0; New York, USA) for the allocation of patients who fulfilled all criteria and were willing to participate in this study. Group I: Patients were instructed to use MI Paste Plus (GC Europe, Leuven, Belgium) according to manufacturers instructions. Group II: Patients were instructed to use (Remin Pro, VOCO , Cuxhaven, Germany) a pea-sized amount of the cream. Group III. Patients (control group) used a 1450 ppm fluoridated tooth paste (Colgate Sensitive Pro-Relief, Colgate-Palmolive, Swidnica, Poland) for conventional tooth brushing and instructed to follow a routine home care. The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months. The primary outcome measures were assessment of mineral loss based on fluorescence loss measurements using QLF. Lesions that scored 1 and 2 according to ICDAS II at debonding were included in the study. The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions. Fluorescent images of the patient were evaluated in the 'White Spot Lesion' option of the analysis program (QA2.v.1.27). Following five QLF measurements were performed;
- Depth of lesion (∆F, %) shows the percentage of loss in fluorescence.
- Lesion area (LA, mm2) refers to the area covered by the demineralized area on the tooth.
- Lesion volume (∆Q, % × mm2) is derived from the combination of lesion area and lesion depth and represents the volume of the affected enamel.
- Maximum fluorescence loss (∆Fmax)is related to depth of lesion and mineral loss. Statistical analysis was performed with IBM® SPSS® (version 26. SPSS Inc., IBM Corporation, NewYork, USA). Descriptive statistics are expressed as number of units (n), percent (%), mean ± standard deviation (x ̅±ss), median (M), minimum (min), maximum (max), and interquartile range (IQR) values. The normal distribution of the data was evaluated with the Shapiro Wilk test of normality. Homogenicity of variances was evaluated with Levene's test.The concordance and differences in the first measurements and the second measurements were evaluated with the intra-class correlation coefficient and the paired samples t test. The ages of the groups were compared with one-way analysis of variance. The ΔF, lesion area and ΔFmax values of the groups in T0, T1, T2 and T3 were compared with two-way analysis of variance in repeated measurements. Bonferroni correction was applied in multiple comparisons. ΔQ, ICDAS II score, and difference values from baseline were compared between groups by Kruskal-Wallis analysis. In case of difference with Kruskal-Wallis analysis, Dunn-Bonferroni test was used for multiple comparisons. For ΔQ, ICDAS II score, Friedman analysis was performed for intragroup timepoint comparisons. Bonferroni correction was applied in multiple comparisons for Friedman analysis. Fisher Exact test was used to compare groups with categorical variables. If the chi-square test result was found to be significant, subgroup analyzes were performed with Bonferroni-corrected two-ratio z-test. Statistical significance level was set at p<0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Izmir
-
Konak, Izmir, Turkey, 35220
- Sevgi Göl Peynirci
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 12 to 25 years of age,
- at least 12 months of orthodontic treatment with braces,
- at least one upper anterior tooth with WSL.
Exclusion Criteria:
- smoking,
- enamel hypoplasia or fluorosis,
- active periodontal disease,
- dentin caries,
- allergy to casein,
- previous bleaching.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MI Paste Plus
Patients were instructed to use MI Paste Plus (GC Europe, Leuven, Belgium) according to manufacturers instructions.
|
Briefly, a pea-sized amount of the cream was used once a day and was allowed to remain on the teeth for three minutes after conventional tooth brushing.
Patient was advised to not to spit out the cream for 30 seconds to activate the product with saliva.
Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.
|
|
Experimental: Remin Pro
Patients were instructed to use (Remin Pro, VOCO GmbH, Cuxhaven, Germany) a pea-sized amount of the cream.
|
The cream must remain on the teeth for at least three minutes once daily after conventional tooth brushing.
Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.
|
|
Active Comparator: Control
Patients used a 1450 ppm fluoridated tooth paste (Colgate Sensitive Pro-Relief, Colgate-Palmolive, Swidnica, Poland) for conventional tooth brushing.
|
Patients instructed to follow a routine home care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mineral Content Assessment (ΔF / Depth of lesion)
Time Frame: The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
|
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
|
Mineral Content Assessment (LA / Lesion area)
Time Frame: The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
|
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
|
Mineral Content Assessment (∆Q / Lesion volume)
Time Frame: The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
|
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
|
Mineral Content Assessment (∆Fmax / Maximum fluorescence loss)
Time Frame: The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
|
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Caries Regression Assessment
Time Frame: The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
ICDAS II scoring
|
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPEYNIRCI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Remineralization
-
Kırıkkale UniversityCompleted
-
Colgate PalmoliveFederal University of ParaíbaNot yet recruitingRemineralization | Enamel Subsurface Lesion | Enamel LesionsBrazil
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityCompletedRemineralization Effect of the Varnish on White Spot LesionsEgypt
-
Colgate PalmoliveFederal University of AlagoasCompletedRemineralization | Enamel Lesions | Demineralization | Dental CavityBrazil
-
Colgate PalmoliveFederal University of AlagoasCompletedRemineralization | Enamel Lesions | Demineralization, Tooth | Dental CavityBrazil
-
Al-Azhar UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingCaries, Dental | Remineralization | White Spot Lesion
-
Cairo UniversityUnknownRemineralization | White Spot Lesion | Caries,DentalEgypt
Clinical Trials on MI Paste Plus
-
Imam Abdulrahman Bin Faisal UniversityUnknownWhite Spot LesionSaudi Arabia
-
University of IowaEnrolling by invitationDental ProsthesisUnited States
-
Universidad Autonoma de San Luis PotosíCompleted
-
Cairo UniversityUnknown
-
University of ZurichBorrow FoundationCompletedErosion ProtectionSwitzerland
-
University of IowaCompletedEdentulous Jaw | Edentulous MouthUnited States
-
Suez Canal UniversityCompleted
-
Suez Canal UniversityCompleted
-
Universidade Federal do ParaCompleted
-
US Department of Veterans AffairsCompletedMyocardial Infarction | ComorbidityUnited States, Puerto Rico